Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Feb;84(2):381-91.
doi: 10.1111/j.1476-5381.1985.tb12922.x.

Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex

Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex

N L Harrison et al. Br J Pharmacol. 1985 Feb.

Abstract

Coronal sections of rat brain (500 micron thick) were trimmed to form 'wedges' of tissue consisting of cerebral cortex and corpus callosum. When these slices were placed in a two-compartment bath, the cortical tissue could be depolarized, relative to the corpus callosum, by superfusions of high K+, or by amino acids such as L-glutamate, L-aspartate, quisqualate, kainate and N-methyl D-aspartate (NMDA). Responses to NMDA were reduced by magnesium ions, by the organic antagonists (-)-2-amino 5-phosphonovalerate (APV) and 2-amino 7-phosphonoheptanoate (APH), and by the dissociative anaesthetic ketamine. In this preparation, all these antagonists shifted the NMDA dose-response curve to the right in a parallel manner. A Schild plot for Mg2+ had a slope significantly less than unity, indicative of a non-competitive action, whilst Schild plots for (-)-APV, APH and ketamine appeared linear and had slopes of approximately 1. Analysis of the results of combination experiments suggested that the presumed competitive antagonists, (-)-APV and APH, share a common site of action as NMDA antagonists, and that this site is distinct from that at which ketamine exerts its action. The action of Mg2+ is clearly different from that of either (-)-APV or ketamine. It is concluded that ketamine is a non-competitive antagonist of NMDA and may act at an allosteric site on the NMDA receptor complex to influence its function.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol. 1978 Jul;63(3):495-502 - PubMed
    1. Br J Pharmacol Chemother. 1964 Oct;23:313-29 - PubMed
    1. Annu Rev Pharmacol Toxicol. 1981;21:165-204 - PubMed
    1. Br J Pharmacol. 1982 Jan;75(1):65-75 - PubMed
    1. Science. 1982 May 21;216(4548):899-901 - PubMed

Publication types

MeSH terms

LinkOut - more resources